Search results: Sage Journals

Open accessResearch articleFirst published 2021

The effect of lemborexant for insomnia disorder

Hidenobu Suzuki, Hiroyuki Hibino

Sage Open Medicine

Restricted accessResearch articleFirst published August, 2022

Lemborexant,an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?

Nicholas A Keks, Judy Hope

Australasian Psychiatry

Open accessResearch articleFirst published June, 2022

Effect of alcohol coadministration on the pharmacodynamics,pharmacokinetics,and safety of lemborexant: A randomized,placebo-controlled crossover study

Ishani Landry, Nancy Hall, Jagadeesh Aluri [...]

Journal of Psychopharmacology

Open accessResearch articleFirst published 2021

Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant

Hidenobu Suzuki, Hiroyuki Hibino

Sage Open Medicine

Open accessBrief reportFirst published May, 2022

Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium

Tatsuto Terada, Takatoshi Hirayama, Ryoichi Sadahiro [...]

Journal of Palliative Medicine

Open accessResearch articleFirst published June 1, 2021

Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant

Carsten T. Beuckmann, Hiroyuki Suzuki, Erik S. Musiek [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2026

Tolerability of lemborexant for cognitive function and sleep quality in patients with dementia with Lewy bodies

Shoya Inagawa, Ryo Yamamoto, Yuta Inagawa [...]

Journal of Alzheimer's Disease Reports

Restricted accessReview articleFirst published February, 2022

Review of the Efficacy and Safety of Lemborexant,a Dual Receptor Orexin Antagonist (DORA),in the Treatment of Adults With Insomnia Disorder

Kristin Waters

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published March, 2026

Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists

Kazuhiro Hada, Yuki Murata, Yoshiaki Ohi [...]

Journal of Alzheimer’s Disease

Open accessReview articleFirst published 2026

Treatment Options for Sleep Disturbances in Dementia: A Systematic Review

Duc Viet Pham, Arnim Quante

Journal of Geriatric Psychiatry and Neurology

Open accessResearch articleFirst published 2021

The effect of lemborexant for insomnia disorder

Hidenobu Suzuki, Hiroyuki Hibino

Sage Open Medicine

Restricted accessResearch articleFirst published August, 2022

Lemborexant,an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?

Nicholas A Keks, Judy Hope

Australasian Psychiatry

Open accessResearch articleFirst published June, 2022

Effect of alcohol coadministration on the pharmacodynamics,pharmacokinetics,and safety of lemborexant: A randomized,placebo-controlled crossover study

Ishani Landry, Nancy Hall, Jagadeesh Aluri [...]

Journal of Psychopharmacology

Open accessResearch articleFirst published 2021

Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant

Hidenobu Suzuki, Hiroyuki Hibino

Sage Open Medicine

Open accessBrief reportFirst published May, 2022

Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium

Tatsuto Terada, Takatoshi Hirayama, Ryoichi Sadahiro [...]

Journal of Palliative Medicine

Open accessResearch articleFirst published June 1, 2021

Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer’s Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant

Carsten T. Beuckmann, Hiroyuki Suzuki, Erik S. Musiek [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2026

Tolerability of lemborexant for cognitive function and sleep quality in patients with dementia with Lewy bodies

Shoya Inagawa, Ryo Yamamoto, Yuta Inagawa [...]

Journal of Alzheimer's Disease Reports

Restricted accessReview articleFirst published February, 2022

Review of the Efficacy and Safety of Lemborexant,a Dual Receptor Orexin Antagonist (DORA),in the Treatment of Adults With Insomnia Disorder

Kristin Waters

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published March, 2026

Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists

Kazuhiro Hada, Yuki Murata, Yoshiaki Ohi [...]

Journal of Alzheimer’s Disease

Open accessReview articleFirst published 2026

Treatment Options for Sleep Disturbances in Dementia: A Systematic Review

Duc Viet Pham, Arnim Quante

Journal of Geriatric Psychiatry and Neurology